$ACONW

Aclarion, Inc.

CIK:0001635077|SEC Filings

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Revenue:
Revenue	$ 25,208	$ 19,319	$ 46,348	$ 38,309
Cost of revenue	16,911	14,179	34,301	37,658
Gross profit	8,297	5,140	12,047	651
Operating expenses:
Sales and marketing	877,160	343,765	1,785,957	646,350
Research and development	297,070	270,434	612,487	468,622
General and administrative	1,733,789	1,127,449	3,500,266	2,114,112
Total operating expenses	2,908,019	1,741,648	5,898,710	3,229,084
Loss from operations	(2,899,722)	(1,736,508)	(5,886,663)	(3,228,433)
Other income (expense):
Gain on extinguishment of debt	0	0	0	73,272
Changes in fair value of warrant and derivative liabilities	0	45	18	11,766
Penalties and settlements	0	0	0	(672,500)
Interest income	157,346	135,865	290,381	178,028
Other, net	(5,175)	(159)	(4,862)	(326)
Total other income (expense)	152,171	135,751	285,537	(409,760)
Loss before income taxes	(2,747,551)	(1,600,757)	(5,601,126)	(3,638,193)
Income tax provision	0	0	0	0
Net loss	(2,747,551)	(1,600,757)	(5,601,126)	(3,638,193)
Dividends on preferred stock	0	0	0	(6,683)
Net loss allocable to common stockholders	$ (2,747,551)	$ (1,600,757)	$ (5,601,126)	$ (3,644,876)
Net loss per share allocable to common stockholders, basic	$ (1.12)	$ (2.75)	$ (2.44)	$ (9.09)
Net loss per share allocable to common stockholders, diluted	$ (1.12)	$ (2.75)	$ (2.44)	$ (9.09)
Weighted average shares of common stock outstanding, basic	2,462,250	582,371	2,296,061	400,868
Weighted average shares of common stock outstanding, diluted	2,462,250	582,371	2,296,061	400,868

Condensed Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (5,601,126)	$ (3,638,193)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	122,778	107,729
Share-based compensation	106,811	84,257
Amendment of warrants	0	48,087
Non-cash settlements	0	58,272
Change in fair value related to warrants and derivative	(18)	(11,766)
Change in operating assets and liabilities
Accounts receivable	1,508	(2,595)
Prepaids and other current assets	(129,339)	(232,111)
Accounts payable	372,842	(268,237)
Accrued and other liabilities	(172,352)	(521,837)
Net cash used in operating activities	(5,298,896)	(4,376,394)
CASH FLOWS FROM INVESTING ACTIVITIES:
Intangible assets – Patents	(90,716)	(121,810)
Fixed assets	(1,808)	(480)
Net cash used in investing activities	(92,524)	(122,290)
CASH FLOWS FROM FINANCING ACTIVITIES:
Public offering of common stock and warrants	0	14,554,545
Registered direct offerings of common stock	1,036,000	5,167,927
Proceeds from direct offering of prefunded warrants	9,323,982	0
Common stock cash issuance costs	(698,889)	(1,959,643)
Exercise of Series C warrants	0	336,441
Redemption of Series B Preferred stock	0	(1,213,590)
Net cash provided by financing activities	9,661,093	16,885,680
Net increase in cash, cash equivalents and restricted cash	4,269,673	12,386,996
Cash, cash equivalents and restricted cash, beginning of period	12,040,789	463,661
Cash, cash equivalents and restricted cash, end of period	16,310,462	12,850,657
Cash paid for interest	0	0
Cash paid for income taxes	800	0
Non-cash activities
Capitalization of Series B preferred stock dividends	0	5,425
Capitalization of Series C preferred stock dividends	0	1,258
Conversion of Series C preferred stock to common stock	0	548,534
Cashless exercise of B warrants to common stock	$ 0	$ 9,539,081

Condensed Balance Sheets - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 16,285,462	$ 12,015,789
Restricted cash	25,000	25,000
Accounts receivable, net	28,172	29,680
Prepaid expense	445,574	316,235
Other current assets	10,000	10,000
Total current assets	16,794,208	12,396,704
Non-current assets:
Property and equipment, net	23,233	24,169
Intangible assets, net	1,222,213	1,251,531
Total non-current assets	1,245,446	1,275,700
Total assets	18,039,654	13,672,404
Current liabilities:
Accounts payable	704,979	332,962
Accrued and other liabilities	331,910	504,262
Warrant liability	45	63
Total current liabilities	1,036,934	837,287
Total liabilities	1,036,934	837,287
Commitments and contingencies (see Note 10)
Stockholders’ equity:
Common stock - $.00001 par value, 200,000,000 authorized,2,462,250 and 854,371 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively (See Note 11)	25	9
Additional paid-in capital	81,099,761	71,331,048
Accumulated deficit	(64,097,066)	(58,495,940)
Total stockholders’ equity	17,002,720	12,835,117
Total liabilities and stockholders’ equity	$ 18,039,654	$ 13,672,404